These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11408971)

  • 41. Back where we belong.
    Critelli MJ
    Harv Bus Rev; 2005 May; 83(5):47-54, 152. PubMed ID: 15929403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lift outs: how to acquire a high-functioning team.
    Groysberg B; Abrahams R
    Harv Bus Rev; 2006 Dec; 84(12):133-40, 164. PubMed ID: 17183798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Master of the house: Why a company should take control of its building projects.
    Thurm D
    Harv Bus Rev; 2005 Oct; 83(10):120-9, 158. PubMed ID: 16250630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innovation versus complexity: what is too much of a good thing?
    Gottfredson M; Aspinall K
    Harv Bus Rev; 2005 Nov; 83(11):62-71, 164. PubMed ID: 16299961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The business against case revolution. An interview with Nestlé's Peter Brabeck. Interview by Sue Wetlaufer.
    Brabeck P
    Harv Bus Rev; 2001 Feb; 79(2):112-9, 157. PubMed ID: 11213685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CFOs and strategists: forging a common framework.
    Rappaport A
    Harv Bus Rev; 1992; 70(3):84-91. PubMed ID: 10118005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Driving drug discovery and patient therapy via the encapsulation and fusion of knowledge.
    Collins MA; Shaw I; Billington DC
    Drug Des Discov; 1999 Nov; 16(3):181-94. PubMed ID: 10624564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Syndication--the emerging model for business in the Internet era.
    Werbach K
    Harv Bus Rev; 2000; 78(3):84-93, 214. PubMed ID: 11183981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Will you survive the services revolution?
    Karmarkar U
    Harv Bus Rev; 2004 Jun; 82(6):100-7, 138. PubMed ID: 15202291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The business of emergency medicine: a model for success.
    Proctor J; Hall P; Carr J
    Emerg Med Clin North Am; 2004 Feb; 22(1):19-45. PubMed ID: 15062495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The trouble I've seen.
    James DN
    Harv Bus Rev; 2002 Mar; 80(3):42-9, 131. PubMed ID: 11894381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From value chain to value constellation: designing interactive strategy.
    Normann R; Ramírez R
    Harv Bus Rev; 1993; 71(4):65-77. PubMed ID: 10127040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An audience with...Joseph Bolen. Interview by Bethan Hughes.
    Bolen J
    Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How industries change.
    McGahan AM
    Harv Bus Rev; 2004 Oct; 82(10):86-94, 156. PubMed ID: 15559578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creating new market space.
    Kim WC; Mauborgne R
    Harv Bus Rev; 1999; 77(1):83-93. PubMed ID: 10345394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How we're fixing up Tyco.
    Pillmore EM
    Harv Bus Rev; 2003 Dec; 81(12):96-103, 126. PubMed ID: 14712548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leading change when business is good. Interview by Paul Hemp and Thomas A. Stewart.
    Palmisano S
    Harv Bus Rev; 2004 Dec; 82(12):60-70, 148. PubMed ID: 15605566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Jordanian pharmaceutical companies: are their marketing efforts paying off?
    Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
    Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.